Abstract Library

#4490 Parietal cell-selective Slc26a9 deletion in mice causes gasdermin D mediates mitochondrial damage and pyroptosis, which is the key event to induce autoimmune gastritis

Introduction: Autoimmune gastritis (AIG) is the basis of gastric malignancy, including neuroendocrine tumour (NET) and gastric cancer (GC). We reported that Slc26a9 is highly expressed in parietal cells (PCs), and its deficiency caused GC.

Conference:

Presenting Author: Liu X

Authors: Ji B, Deng Z, Ma Z, Li T, Tuo B,

Keywords: Slc26a9, autoimmune gastritis, Pyroptosis, gastric mucosal immunity remodelling,

#3970 Unveiling racial disparities in hepatic neuroendocrine tumors: A comprehensive analysis

Introduction: Investigating the impact of race on the clinicopathologic features and prognosis of hepatic neuroendocrine tumors is a complex and important area of research. Notably, there are significant differences in the clinical presentation, pathologic features, and prognosis of hepatic neuroendocrine tumors across racial groups.

Conference:

Presenting Author:

Authors: Han D, Zhang Z, Du H,

Keywords: Ethnicity, Prognosis, Neuroendocrine tumor, Independent prognostic factor,

#2131 Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma

Introduction: Primary gallbladder neuroendocrine carcinoma is a relatively rare disease.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Zhang Y

Authors: Zhang Y, Chen X, Wang Y, Zhao J, Li Z,

Keywords: gallbladder neuroendocrine carcinoma, clinicopathological features, prognosis,

#1743 FOLFIRI Regimen with or without Bevacizumab As Second-Line Therapy Showed Activity in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Introduction: Metastatic disease of GEP-NEC is tough condition in clinical practice. And the role of the second-line therapy remains unknown

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: ZHIYU C

Authors: Chen Z, Zhao X, Wang C, Zhang W, Zhu X,

Keywords: NEC, FOLFIRI, bevacizumab ,